2023-12-012024-11-302024-11-30false00686142ALAN STOCKLEY & COMPANY LIMITED2025-08-26falseiso4217:GBPxbrli:pure006861422023-11-30006861422024-11-30006861422023-12-012024-11-30006861422022-11-30006861422023-11-30006861422022-12-012023-11-3000686142bus:SmallEntities2023-12-012024-11-3000686142bus:AuditExempt-NoAccountantsReport2023-12-012024-11-3000686142bus:FullAccounts2023-12-012024-11-3000686142bus:PrivateLimitedCompanyLtd2023-12-012024-11-3000686142core:WithinOneYear2024-11-3000686142core:AfterOneYear2024-11-3000686142core:WithinOneYear2023-11-3000686142core:AfterOneYear2023-11-3000686142core:ShareCapital2024-11-3000686142core:SharePremium2024-11-3000686142core:RevaluationReserve2024-11-3000686142core:OtherReservesSubtotal2024-11-3000686142core:RetainedEarningsAccumulatedLosses2024-11-3000686142core:ShareCapital2023-11-3000686142core:SharePremium2023-11-3000686142core:RevaluationReserve2023-11-3000686142core:OtherReservesSubtotal2023-11-3000686142core:RetainedEarningsAccumulatedLosses2023-11-3000686142core:LandBuildings2024-11-3000686142core:PlantMachinery2024-11-3000686142core:Vehicles2024-11-3000686142core:FurnitureFittings2024-11-3000686142core:OfficeEquipment2024-11-3000686142core:NetGoodwill2024-11-3000686142core:IntangibleAssetsOtherThanGoodwill2024-11-3000686142core:ListedExchangeTraded2024-11-3000686142core:UnlistedNon-exchangeTraded2024-11-3000686142core:LandBuildings2023-11-3000686142core:PlantMachinery2023-11-3000686142core:Vehicles2023-11-3000686142core:FurnitureFittings2023-11-3000686142core:OfficeEquipment2023-11-3000686142core:NetGoodwill2023-11-3000686142core:IntangibleAssetsOtherThanGoodwill2023-11-3000686142core:ListedExchangeTraded2023-11-3000686142core:UnlistedNon-exchangeTraded2023-11-3000686142core:LandBuildings2023-12-012024-11-3000686142core:PlantMachinery2023-12-012024-11-3000686142core:Vehicles2023-12-012024-11-3000686142core:FurnitureFittings2023-12-012024-11-3000686142core:OfficeEquipment2023-12-012024-11-3000686142core:NetGoodwill2023-12-012024-11-3000686142core:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3000686142core:ListedExchangeTraded2023-12-012024-11-3000686142core:UnlistedNon-exchangeTraded2023-12-012024-11-3000686142core:MoreThanFiveYears2023-12-012024-11-3000686142core:Non-currentFinancialInstruments2024-11-3000686142core:Non-currentFinancialInstruments2023-11-3000686142dpl:CostSales2023-12-012024-11-3000686142dpl:DistributionCosts2023-12-012024-11-3000686142core:LandBuildings2023-12-012024-11-3000686142core:PlantMachinery2023-12-012024-11-3000686142core:Vehicles2023-12-012024-11-3000686142core:FurnitureFittings2023-12-012024-11-3000686142core:OfficeEquipment2023-12-012024-11-3000686142dpl:AdministrativeExpenses2023-12-012024-11-3000686142core:NetGoodwill2023-12-012024-11-3000686142core:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3000686142dpl:GroupUndertakings2023-12-012024-11-3000686142dpl:ParticipatingInterests2023-12-012024-11-3000686142dpl:GroupUndertakingscore:ListedExchangeTraded2023-12-012024-11-3000686142core:ListedExchangeTraded2023-12-012024-11-3000686142dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-12-012024-11-3000686142core:UnlistedNon-exchangeTraded2023-12-012024-11-3000686142dpl:CostSales2022-12-012023-11-3000686142dpl:DistributionCosts2022-12-012023-11-3000686142core:LandBuildings2022-12-012023-11-3000686142core:PlantMachinery2022-12-012023-11-3000686142core:Vehicles2022-12-012023-11-3000686142core:FurnitureFittings2022-12-012023-11-3000686142core:OfficeEquipment2022-12-012023-11-3000686142dpl:AdministrativeExpenses2022-12-012023-11-3000686142core:NetGoodwill2022-12-012023-11-3000686142core:IntangibleAssetsOtherThanGoodwill2022-12-012023-11-3000686142dpl:GroupUndertakings2022-12-012023-11-3000686142dpl:ParticipatingInterests2022-12-012023-11-3000686142dpl:GroupUndertakingscore:ListedExchangeTraded2022-12-012023-11-3000686142core:ListedExchangeTraded2022-12-012023-11-3000686142dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-12-012023-11-3000686142core:UnlistedNon-exchangeTraded2022-12-012023-11-3000686142core:NetGoodwill2024-11-3000686142core:IntangibleAssetsOtherThanGoodwill2024-11-3000686142core:LandBuildings2024-11-3000686142core:PlantMachinery2024-11-3000686142core:Vehicles2024-11-3000686142core:FurnitureFittings2024-11-3000686142core:OfficeEquipment2024-11-3000686142core:AfterOneYear2024-11-3000686142core:WithinOneYear2024-11-3000686142core:ListedExchangeTraded2024-11-3000686142core:UnlistedNon-exchangeTraded2024-11-3000686142core:ShareCapital2024-11-3000686142core:SharePremium2024-11-3000686142core:RevaluationReserve2024-11-3000686142core:OtherReservesSubtotal2024-11-3000686142core:RetainedEarningsAccumulatedLosses2024-11-3000686142core:NetGoodwill2023-11-3000686142core:IntangibleAssetsOtherThanGoodwill2023-11-3000686142core:LandBuildings2023-11-3000686142core:PlantMachinery2023-11-3000686142core:Vehicles2023-11-3000686142core:FurnitureFittings2023-11-3000686142core:OfficeEquipment2023-11-3000686142core:AfterOneYear2023-11-3000686142core:WithinOneYear2023-11-3000686142core:ListedExchangeTraded2023-11-3000686142core:UnlistedNon-exchangeTraded2023-11-3000686142core:ShareCapital2023-11-3000686142core:SharePremium2023-11-3000686142core:RevaluationReserve2023-11-3000686142core:OtherReservesSubtotal2023-11-3000686142core:RetainedEarningsAccumulatedLosses2023-11-3000686142core:NetGoodwill2022-11-3000686142core:IntangibleAssetsOtherThanGoodwill2022-11-3000686142core:LandBuildings2022-11-3000686142core:PlantMachinery2022-11-3000686142core:Vehicles2022-11-3000686142core:FurnitureFittings2022-11-3000686142core:OfficeEquipment2022-11-3000686142core:AfterOneYear2022-11-3000686142core:WithinOneYear2022-11-3000686142core:ListedExchangeTraded2022-11-3000686142core:UnlistedNon-exchangeTraded2022-11-3000686142core:ShareCapital2022-11-3000686142core:SharePremium2022-11-3000686142core:RevaluationReserve2022-11-3000686142core:OtherReservesSubtotal2022-11-3000686142core:RetainedEarningsAccumulatedLosses2022-11-3000686142core:AfterOneYear2023-12-012024-11-3000686142core:WithinOneYear2023-12-012024-11-3000686142core:Non-currentFinancialInstrumentscore:CostValuation2023-12-012024-11-3000686142core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-012024-11-3000686142core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-012024-11-3000686142core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-012024-11-3000686142core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-012024-11-3000686142core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-012024-11-3000686142core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-012024-11-3000686142core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-012024-11-3000686142core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-012024-11-3000686142core:Non-currentFinancialInstrumentscore:CostValuation2024-11-3000686142core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-3000686142core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-3000686142core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-3000686142core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-3000686142core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-3000686142core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-3000686142core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-3000686142core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-3000686142core:Non-currentFinancialInstrumentscore:CostValuation2023-11-3000686142core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-3000686142core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-3000686142core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-3000686142core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-3000686142core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-3000686142core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-3000686142core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-3000686142core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-3000686142bus:Director12023-12-012024-11-30

ALAN STOCKLEY & COMPANY LIMITED

Registered Number
00686142
(England and Wales)

Unaudited Financial Statements for the Year ended
30 November 2024

ALAN STOCKLEY & COMPANY LIMITED
Company Information
for the year from 1 December 2023 to 30 November 2024

Director

Mr Benjamin AMPOMAH

Registered Address

The Pharmacy
37 Lynn Road Snettisham
Kings Lynn
PE31 7LR

Registered Number

00686142 (England and Wales)
ALAN STOCKLEY & COMPANY LIMITED
Balance Sheet as at
30 November 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets390,29042,051
90,29042,051
Current assets
Stocks484,25079,222
Debtors5990,827900,875
Cash at bank and on hand61,45077,732
1,136,5271,057,829
Creditors amounts falling due within one year6(528,116)(466,915)
Net current assets (liabilities)608,411590,914
Total assets less current liabilities698,701632,965
Creditors amounts falling due after one year7(13,925)(23,174)
Net assets684,776609,791
Capital and reserves
Called up share capital2,0002,000
Profit and loss account682,776607,791
Shareholders' funds684,776609,791
The financial statements were approved and authorised for issue by the Director on 26 August 2025, and are signed on its behalf by:
Mr Benjamin AMPOMAH
Director
Registered Company No. 00686142
ALAN STOCKLEY & COMPANY LIMITED
Notes to the Financial Statements
for the year ended 30 November 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The address of the registered office is The Pharmacy, 37 Lynn Road, Snettisham, Kings Lynn, PE31 7LR, Norfolk.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Revenue from sale of goods
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Land and buildings15
Plant and machinery15
Vehicles25
Stocks and work in progress
Inventories are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20242023
Average number of employees during the year1313
3.Tangible fixed assets

Land & buildings

Plant & machinery

Vehicles

Total

££££
Cost or valuation
At 01 December 2360,85675,4908,354144,700
Additions--65,99065,990
At 30 November 2460,85675,49074,344210,690
Depreciation and impairment
At 01 December 2334,90266,3441,403102,649
Charge for year3,8931,37212,48617,751
At 30 November 2438,79567,71613,889120,400
Net book value
At 30 November 2422,0617,77460,45590,290
At 30 November 2325,9549,1466,95142,051
4.Stocks

2024

2023

££
Finished goods84,25079,222
Total84,25079,222
5.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables244,591251,595
Amounts owed by group undertakings727,958633,958
Other debtors17,50415,038
Prepayments and accrued income774284
Total990,827900,875
6.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables198,699219,412
Bank borrowings and overdrafts10,00010,000
Amounts owed to related parties124,16158,971
Taxation and social security24,85934,795
Payments received on account113,525115,846
Other creditors43,3716,891
Accrued liabilities and deferred income13,50121,000
Total528,116466,915
7.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts13,92523,174
Total13,92523,174
8.Related party transactions
At the year-end, Ben Amp Holdings Ltd owed £727,958 (2023: £633,958) to Alan Stockley & Company Ltd. Alan Stockley & Company Ltd owed £99,798 (2023: £34,608) to A.B. Chemist Ltd and £24,364 (2023: £24,364) to The Chemist Shop Ltd. The companies are related as Mr. Benjamin Ampomah is also a director in these companies.